Can-Fite BioPharma Proposes Warrant Exercise Incentives
Company Announcements

Can-Fite BioPharma Proposes Warrant Exercise Incentives

Can-Fite BioPharma (CANF) has released an update.

Can-Fite BioPharma Ltd. has announced an inducement offer for warrant holders to exercise their purchase rights of ordinary shares represented by American Depositary Shares at a price of $1.75. In return, the company is offering new warrants with an exercise price of $2.25, which are exercisable between 20 months to five years, depending on the terms. These new warrants and any underlying shares will initially be unregistered and subject to certain restrictions.

For further insights into CANF stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskCan-Fite BioPharma Secures Australian Patent for Obesity Drug
TheFlyCan-Fite BioPharma announces an update related to IP status of Namodenoson
TipRanks Auto-Generated NewsdeskCan-Fite BioPharma Secures Lucrative Deal with Vetbiolix
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App